E-Clinical Solutions Market Size to Surpass USD 20.54 Billion by 2029, Size, Share, Emerging Trends, Business Strategies and Competitive Landscape

Rhea-AI Summary

Data Bridge Market Research has published a report on the E-Clinical Solutions Market, projecting growth from USD 7.2 billion in 2021 to USD 20.54 billion by 2029, at a CAGR of 14.0% during 2022-2029. The report analyzes key growth strategies, market drivers, and competitive landscapes, emphasizing the rising demand for electronic health records and clinical data management systems. Government support for clinical research in emerging economies such as India and China is highlighted as a significant opportunity for market expansion.

Positive

• Projected market growth from USD 7.2 billion in 2021 to USD 20.54 billion by 2029.
• Expected CAGR of 14.0% during 2022-2029.
• Government support for clinical trials in emerging markets presents significant opportunities.

Negative

• None.

BOSTON, Jan. 12, 2023 /PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "E-Clinical Solutions Market" The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. An all-inclusive E-Clinical Solutions report includes a range of inhibitors as well as driving forces of the market which are analysed in both qualitative and quantitative approach so that readers and users get precise information and insights about E-Clinical Solutions industry. Statistical data mentioned in the report is symbolized with the help of graphs which simplifies the understanding of facts and figures. The market report helps define commerce strategies to the businesses of small, medium as well as large size. The analysis and estimations conducted via the finest E-Clinical Solutions business report help to get an idea about the product launches, future products, joint ventures, marketing strategy, developments, mergers and acquisitions and effect of the same on sales, marketing, promotions, revenue, import, export, and CAGR values.

Data Bridge Market Research analyses that the e-clinical solutions market which was USD 7.2 billion in 2021, would rocket up to USD 20.54 billion by 2029, and is expected to undergo a CAGR of 14.0% during the forecast period 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download Sample Copy of E-Clinical Solutions Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-eclinical-solutions-market

Market Overview:

Electronic health records, electronic permission forms, integrating e-technologies, electronic data collection, and clinical data management systems are all part of the e-clinical solutions industry. E-clinical solutions provide end-to-end clinical research solutions are provided by e-clinical solutions, which enable researchers to manage the lengthy clinical research process. It assists clinical research businesses with regulatory document management, team collaboration and supply chain management, site performance management, and reporting, all driving demand for e-clinical solutions in the projection period.

According to World Economic Forum estimates from 2019, hospitals produce roughly 50 petabytes of data per year. Clinical notes, lab tests, medical imaging, sensor readings, genomics, and operational and financial data are all included in the data. In this domain, e-clinical solutions are projected to have a substantial influence. The amount of data produced by the Internet of Things (IoT) and the digitization of healthcare is immense, and it contains information that can be quickly retrieved through electronic data mining, which was previously unattainable with paper records.

Opportunities for Players:

• Growing clinical research activities and government support in emerging economies

In the future years, the expanding clinical trials efforts in emerging nations such as Indonesia, Mexico, China, India, and Brazil to create affordable therapies are projected to present attractive prospects in the worldwide eClinical solutions market. Furthermore, rising government grants to reform public healthcare and offer more people with easier access to pharmaceuticals would propel the eClinical market forward during the projection period. Furthermore, because to the rapid rise of pharmaceutical companies in emerging economies such as India and China, it is estimated that roughly 28% of total clinical trials were undertaken in Asia.

• Rising government grants and financing for clinical trials

The rapid expansion of clinical research activities in developing economies and a shift in preference from manual data interpretation to real-time data analysis during clinical trials will continue to drive the global eClinical solutions market.

Some of the major players operating in the E-Clinical Solutions market are:

• Parexel International Corporation (US)
• Oracle (US)
• Medidata Solutions, Inc. (US)
• Veeva Systems (U.S)
• ERT Clinical (US)
• IBM Corporation (US)
• Clario (U.S.)
• ArisGlobal (U.S.)
• Anju Software, Inc's (U.S.)
• Bio-Optronics, Inc. (U.S.)
• DATATRAK Int. (U.S.)
• ICON (U.S.)
• MasterControl, Inc.(U.S.)
• OmniComm Systems, Inc. (US)
• RESONANCE HEALTH (Australia)
• Signant Health (US)
• Xybion Corporation (US)

Get Full PDF Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-eclinical-solutions-market

Recent Development

• In April 2021, With the advent of SmartSignalsTM e-consent, Signant Health has expanded its electronic informed consent options and capabilities. Sponsors now have more control over getting electronic informed consent and re-consent for any research design thanks to changes to key products' functionality and tiered licence options.
• On July 21, 2021 – e-clinical Solutions LLC has launched the latest update of the illuminating Clinical Data CloudTM, which includes new visualizations, enhanced analytics, and increased automation of data review and mapping capabilities across the platform.

Answers That the Report Acknowledges:

• Market size and growth rate during forecast period.
• Key factors driving the "E-Clinical Solutions Industry"
• Key market trends cracking up the growth of the "E-Clinical Solutions Market"
• Challenges to market growth.
• Key vendors of "E-Clinical Solutions Market"
• Detailed SWOT analysis.
• Opportunities and threats faces by the existing vendors in Global "E-Clinical Solutions Market" market.
• Trending factors influencing the market in the geographical regions.
• Strategic initiatives focusing the leading vendors.
• PEST analysis of the market in the five major regions.

Market Dynamics: E-Clinical Solutions Market

• Upsurge in the research and development proficiencies

Other market growth variables include an increase in the use rate of e-clinical solutions for greater data standardization and an increase in government funding and grants to assist clinical studies. Other major variables that will offer attractive market growth prospects include increasing westernization, increasing acceptance of novel software solutions in clinical research, and increasing medical tourism

• Increasing R&D expenditure on drug development

The increasing adoption of e-clinical solutions among pharmaceutical and medical device companies to reduce the number of challenges encountered while commercializing existing and developing new products is one of the major factors driving the global e-clinical solutions market forward during the forecast period of 2022 to 2029. Furthermore, as the costs and hazards of creating novel therapies, particularly those related to drug trials, continue to rise, global demand for e-clinical solutions is projected to rise.

• Significant growth in the biopharmaceutical industries

Pharmaceutical companies use e-clinical solutions to obtain regulatory approval for newly discovered medicines and drugs. Furthermore, the rising frequency of chronic medical conditions and the growing elderly population, both of which require rapid medical attention, are propelling the market forward. As the coronavirus disease (COVID-19) continues to spread over the world, the demand for eClinical solutions to create and monitor vaccine administration and manage patient data has grown significantly. In accordance with this, healthcare providers' increased embrace of smart medical devices for greater data standards is also fueling market expansion.

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-eclinical-solutions-market

Key Industry Segmentation: E-Clinical Solutions Market

By Product

• Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
• Clinical Trial Management Systems (CTMS)
• Electronic Clinical Outcome Assessment (eCOA)
• Randomization and Trial Supply Management Solution (RTMS)
• Safety Solutions
• Analytics and Reporting Platforms
• Integration Platforms
• Electronic Trial Master File (eTMF)

By Delivery Mode

• Web-hosted (On-Demand)
• Licensed Enterprise (On-premise)
• Cloud-based/software-as-a-service (SaaS)

By Development Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By End-User

• Academic Institutes
• Medical Device Manufactures
• Hospitals
• CROs
• Pharmaceutical & Biotechnology Companies

Regional Analysis/Insights: E-Clinical Solutions Market

The countries covered in the e-clinical solutions market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and Rest of Europe in Europe.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Table of Contents:

1. Introduction
2. Market Segmentation
3. Executive Summary
4. Premium Insights
5. Global E-Clinical Solutions Market: Regulations
6. Market Overview
7. Global E-Clinical Solutions Market, By Product
8. Global E-Clinical Solutions Market, By Delivery Mode
9. Global E-Clinical Solutions Market, By Development Phase
10. Global E-Clinical Solutions Market, By End User
11. Global E-Clinical Solutions Market, By Region
12. Global E-Clinical Solutions Market: Company Landscape
13. SWOT Analyses
14. Company Profile
15. Questionnaires
16. Related Reports

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-eclinical-solutions-market

Explore More Reports:

Europe e-Clinical Solutions Market, By Product (Electronic Clinical Outcome Assessment (ECOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM), Clinical Data Integration Platforms, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions and Other e-Clinical Solutions), Deployment (Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions and Licensed Enterprise (On-Premise) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III and Phase IV), End-User (Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma and Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies and Academic Institutes) https://www.databridgemarketresearch.com/reports/europe-e-clinical-solutions-market

Asia-Pacific eClinical Solutions Market, By Product (Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Clinical Trial Management Systems (CTMS), Electronic Clinical Outcome Assessment (ECOA), Electronic Trial Master File Systems, Clinical Analytics Platforms, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms, Other), Deployment Mode (Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions, Licensed Enterprise (On-Premise) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), End User (Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma and Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies, Academic Institutes), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) https://www.databridgemarketresearch.com/reports/asia-pacific-eclinical-solutions-market

Europe eClinical Solutions Market, By Product (Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Clinical Trial Management Systems (CTMS), Electronic Clinical Outcome Assessment (ECOA), Electronic Trial Master File Systems, Clinical Analytics Platforms, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms and Other), Deployment Mode (Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions and Licensed Enterprise (On-Premise) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III and Phase IV), End User (Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma and Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies and Academic Institutes), Country (Germany, United Kingdom, Italy, France, Russia, Switzerland, Netherlands, Spain, Turkey, Belgium and Rest of Europe) https://www.databridgemarketresearch.com/reports/europe-eclinical-solutions-market

Middle East and Africa eClinical Solutions Market, By Product (Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Clinical Trial Management Systems (CTMS), Electronic Clinical Outcome Assessment (ECOA), Electronic Trial Master File Systems, Clinical Analytics Platforms, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms and Other), Deployment Mode (Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions and Licensed Enterprise (On-Premise) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III and Phase IV), End User (Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma and Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies and Academic Institutes), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-eclinical-solutions-market

North America eClinical Solutions Market, By Product (Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Clinical Trial Management Systems (CTMS), Electronic Clinical Outcome Assessment (ECOA), Electronic Trial Master File Systems, Clinical Analytics Platforms, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms and Other), Deployment Mode (Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions and Licensed Enterprise (On-Premise) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III and Phase IV), End User (Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma and Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies and Academic Institutes), Country (U.S., Canada and Mexico) https://www.databridgemarketresearch.com/reports/north-america-eclinical-solutions-market

Clinical Laboratory Services Market, By Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing and Genetic Testing), Provider (Independent and Reference Laboratories, Hospital-Based Laboratories and Nursing and Physician Office-Based Laboratories), Application (Drug Discovery Related Services, Drug Development Related Services, Bioanalytical and Lab Chemistry Services, Toxicology Testing Services, Cell and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services and Other Clinical Laboratory Services), Service Type (Routine Testing Services, Esoteric Services And Anatomic Pathology Services) https://www.databridgemarketresearch.com/reports/global-clinical-laboratory-services-market

Clinical Trial Consumables Market, By Service (Manufacturing, Packaging and Labeling, Logistics and Distribution), Phase (Phase I, Phase II, Phase III), Therapeutic Area (Oncology, CNS and Mental Disorders, Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases, Blood Disorders, Dermatology, Others), End User (Pharmaceutical and Biotechnology companies, Contract Research Organisations (CROs) and Medical Devices Companies), Distribution Channel (Dermatology Clinics, Hospitals, Pharmacies and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-clinical-trial-consumables-market

Clinical Trials Market, By Phase (Phase I, Phase II, Phase III, Phase IV), Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, Others), Design (Interventional, Treatment Studies, Observational Studies, Expanded Access), End User (Hospital, Laboratories, Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-clinical-trials-market

Clinical Chemistry Analyzer Market, By Product (Analyzers, Reagents, Calibrators, Controls, Standards, Others, Others) Analyzer Technology (Semi-Automated Clinical Chemistry Analyzers, Fully Automated Clinical Chemistry Analyzers)  Test Analysis (Basic Metabolic Panel(BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, Thyroid Function Panel) End User Analysis (Hospitals, Academic Research Centers, Diagnostic Laboratories, Others) https://www.databridgemarketresearch.com/reports/global-clinical-chemistry-analyzer-market

Clinical Trial Management System (CTMS) Market, By Type (Enterprise, Site),  Delivery (Web-Based, Cloud-Based, and On premise), Component (Software, Service), End User (Pharmaceutical and Biotechnology Firms, CROs, and Medical Device Firms), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-clinical-trial-management-system-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/e-clinical-solutions-market-size-to-surpass-usd-20-54-billion-by-2029--size-share-emerging-trends-business-strategies-and-competitive-landscape-301720355.html

SOURCE Data Bridge Market Research

FAQ

What is the projected growth of the E-Clinical Solutions Market by 2029?

The E-Clinical Solutions Market is projected to grow from USD 7.2 billion in 2021 to USD 20.54 billion by 2029.

What is the expected CAGR for the E-Clinical Solutions Market from 2022 to 2029?

The expected CAGR for the E-Clinical Solutions Market during 2022-2029 is 14.0%.

Which countries are mentioned as having growing opportunities in the E-Clinical Solutions Market?

Emerging economies such as India, China, Indonesia, Mexico, and Brazil are mentioned as having growing opportunities.